-
FIGS is preparing to report third quarter 2026 results, with Wall Street expecting higher earnings supported by stronger revenue from its healthcare apparel and lifestyle offering.
-
Analysts are watching how FIGS converts healthcare professionals' recurring uniform budgets into direct to consumer sales while managing freight and tariff costs that affect margins.
-
This article will examine how these earnings expectations and operational factors may influence the investment narrative ahead of the upcoming quarterly update.
Scan how FIGS fits alongside other consumer brands with recurring demand patterns by reviewing our hand picked 18 high quality undiscovered gems in similar cash generative niches.
FIGS Investment Narrative Recap
To own FIGS, you need to believe the brand can keep turning recurring healthcare uniform budgets into steady direct to consumer demand, while holding on to its premium positioning. The near term hinge is simple. Execution against the roughly 20% revenue growth outlook for the upcoming quarter is what many investors will be watching most closely.
The biggest operational risk is that rising freight surcharges, tariffs and any renewed supply chain disruption eat into FIGS' historically strong gross margin profile faster than cost efficiencies can offset. The recent share price move on optimism ahead of earnings does not change that cost and supply picture in a meaningful way.
The move in FIGS shares after the Oppenheimer target increase is most relevant as a sentiment event ahead of the 5 November report. A 6% single day move tightens the margin for error around that earnings release, because more upbeat expectations are now reflected in the price.
For you, that means the upcoming quarter becomes even more of a catalyst. Solid revenue delivery, evidence that freight and tariff pressures remain manageable, and continued traction in non scrub categories and international markets could support the business narrative. Any stumble against those operational markers could weigh more heavily after a strong run in the FIGS stock price.
FIGS Earnings Assumptions in Focus
Analyst models around FIGS spell out a clear hurdle. Consensus expects revenue to compound at 10.1% a year over the next three years, with current earnings of US$61.9 million projected to reach US$78.0 million by 2029, even as profit margins ease from 8.7% today to 8.2% in that period. That implies an earnings increase of about US$16.1 million to meet the 2029 consensus level.
FIGS' narrative projects US$948.0 million revenue and US$78.0 million earnings by 2029. This implies 10.1% yearly revenue growth and an earnings increase of about US$16.1 million from current earnings of US$61.9 million.
Uncover how FIGS' fair value indicates a 14% potential downside to its current price, leaving little room for error.
Exploring Other Perspectives
One alternate view on FIGS leans into the Teams and Community Hub channels as the real swing factor. On this logic, the most optimistic analysts were penciling in revenue of about US$962.7 million and earnings near US$76.6 million by 2029. Those projections were set before this week's target hike and price move, and opinions may evolve as fresh data lands.
Explore 4 other FIGS fair value estimates , including one that suggests it could be worth as much as $22.00.
Decide For Yourself
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
-
A great starting point for your FIGS research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
-
See our latest analysis for FIGS. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate FIGS' overall financial health at a glance.
Looking For More Ideas Beyond FIGS?
If you want to stress test your FIGS thesis, compare it with other businesses that have different risk, return and balance sheet profiles using the Simply Wall St Screener. Seeing how alternative opportunities stack up can sharpen your decision making and help you position FIGS within a broader watchlist.
-
For investors who care most about quality at a reasonable entry point, review our hand picked 30 high quality undervalued stocks that combine strong fundamentals with potentially attractive pricing.
-
If durable balance sheets matter to you more than rapid expansion, weigh FIGS against a list of solid balance sheet and fundamentals (23 results) to see which companies better fit a capital preservation mindset.
-
When capital protection is your priority and you prefer steadier profiles, compare FIGS with a 30 resilient stocks with low risk scores that screens for businesses with lower risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include FIGS .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
